Cor Vasa 2010, 52(3):149-153 | DOI: 10.33678/cor.2010.041
Characteristics of patients on the waiting list for heart transplantation
- Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, Česká republika
Introduction: The waiting list for heart transplantation comprises patients with advanced heart failure in whom all other therapeutic options have failed and who meet the criteria for heart transplantation.
Waiting list analysis: As of 22 June 2009, the waiting list for heart transplantation included 51 patients. Ninety percent of these were individuals with coronary heart disease or dilated cardiomyopathy. The median waiting time was 307 days for urgent patients, and 398 days for those listed as normal status candidates. Severe pulmonary hypertension was present in 22% of patients, median B-natriuretic peptide concentration was 517.9 nith high inter-individual variability. Eighty percent of patients were treated using non-pharmacological management of heart failure, most often by myocardial revascularization, placement of an implantable cardioverter--defibrillator, and cardiac resynchronization therapy. Preformed anti-HLA antibodies were detected in 20% of patients.
Conclusion: We hope this analysis of and discussion about the techniques of management of patients with advanced heart failure may furnish information of interest for the clinical cardiologist and be helpful in improving care of these patients.
Keywords: Heart failure; Heart transplantation; B-natriuretic peptide
Published: March 1, 2010 Show citation
References
- Taylor DO, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant 2008;27:943-956.
Go to original source...
Go to PubMed...
- Pirk J, Málek I, et al. Transplantace srdce. 1. vyd. Praha: Karolinum, 2008. 287 s.
- Málek I. Indikace k transplantaci srdce. Cor Vasa 2008;50:129-132.
Go to original source...
- Kubánek M, Málek I, Kautzner J, et al. The value of B-type natriuretic peptide and big endothelin-1 for detection of severe pulmonary hypertension in heart transplant candidates. European J Heart Failure 2005;7: 1149-1155.
Go to original source...
Go to PubMed...
- Thackray S, Easthaugh J, Freemantle N, et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure - a meta-regression analysis. Eur J Heart Failure 2002;4:515-529.
Go to original source...
- Málek I. Transplantace srdce. Pohled kardiologa. 1. vyd. Praha: Triton, 2004. 78 s.
- Kakáč J, Málek I, Hrnčárek M, et al. Testování plicní hypertenze u kandidátů ortotopické transplantace srdce pomocí prostaglandinu E1. Cor Vasa 1996;38:251-257.
- Jabbour A, Keogh A, Hayward Ch, Macdonald P. Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation. European J Heart Failure 2007;9:674-677.
Go to original source...
Go to PubMed...
- Cihlová M, Al-Hiti H, Melenovský V, et al. Léčba závažné plicní hypertenze sildenafilem u kandidáta transplantace srdce pro pokročilé srdeční selhání. Cor Vasa 2009;51:279-281.
Go to original source...
- Martin J, Siegenthaler MP, Friesewinkel O, et al. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation - a preliminary study. Eur J Cardiothorac Surg 2004;25:971-977.
Go to original source...
Go to PubMed...
- Januzzi JL, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2006;95:948-954.
Go to original source...
Go to PubMed...
- Kubánek M, Goode KM, Lánská V, et al. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Failure 2009;11:367-377.
Go to original source...
Go to PubMed...
- Pfisterer M, Buser P, Rickl H, et al. BNP-guided vs symptom-guided heart failure therapy. The trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Randomised trial. JAMA 2009;301:383-392.
Go to original source...
Go to PubMed...
- Nielsen OW, Cowburn PJ, Sajadieh A, et al. Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care. Eur J Heart Failure 2007;9:1178-1185.
Go to original source...
Go to PubMed...
- Burnett JC Jr. The history of biomarkers. Heart Failure 2009, Nice, France. Satellite symposium: new opportunities in heart failure with novel biomarkers.
- Kubánek M, Lánská V, Hegarová M, et al. Predikce změny tlaku v zaklínění pomocí opakovaného stanovení B-natriuretického peptidu. XVII. výroční sjezd České kardiologické společnosti. Brno, CZ, 10. 5.-13. 5. 2009. Abstr. č. 438. Dostupné na internetu: http://www.kardio-cz.cz.
- Saba S, Atiga WL, Barrington W, et al. Selected patients listed for cardiac transplantation may benefit from defibrillator implantation regardless of an established indication. J Heart Lung Transplant 2003;22:411-418.
Go to original source...
Go to PubMed...
- Vanderheyden M, Wellens F, Bartunek J, et al. Cardiac resynchronization therapy delays heart transplantation in patients with end-stage heart failure and mechanical dyssynchrony. J Heart Lung Transplant 2006;25:447-453.
Go to original source...
Go to PubMed...
- Florian M, Kautzner J, Pirk J, Málek I. Myocardial revascularization in patients with severe left ventricular systolic dysfunction. Cor Vasa 2004;46:575-580.
- Kobashigawa J, Mehra M, West L, et al. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant 2009;28:213-225.
Go to original source...
Go to PubMed...
- Leech SH, Lopez-Cepero M, LeFor WM, et al. Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin. Clin Transplant 2006;20:476-484.
Go to original source...
Go to PubMed...
- Rostaing L, Guibeau-Frugier C, Kamar N. Rituximab for humoral rejection after kidney transplantation: an update. Transplantation 2009;87:1261.
Go to original source...
Go to PubMed...